Free Trial
LON:AMYT

Amryt Pharma (AMYT) Share Price, News & Analysis

Amryt Pharma logo

About Amryt Pharma Stock (LON:AMYT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
90,726 shs
Average Volume
469,552 shs
Market Capitalization
£457.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AMYT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amryt Pharma and its competitors with MarketBeat's FREE daily newsletter.

AMYT Stock News Headlines

Amryt Pharma plc (AMYT)
Utah’s New Oil Find
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.
See More Headlines

AMYT Stock Analysis - Frequently Asked Questions

Shares of AMYT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Amryt Pharma investors own include The Parkmead Group (PMG), Providence Resources (PVR), Ryanair (RYA), AIB Group (AIBG), Atalaya Mining (ATYM), Bank of Ireland Group (BIRG) and C&C Group (CCR).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Pharmaceutical Products
Current Symbol
LON:AMYT
Previous Symbol
LON:FAST
CIK
N/A
Fax
N/A
Employees
290
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
66.05
Current Ratio
1.80
Quick Ratio
1.14

Sales & Book Value

Annual Sales
£210.24 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
3.68
Book Value
GBX 96.60 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
319,657,000
Free Float
N/A
Market Cap
£457.11 million
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (LON:AMYT) was last updated on 8/16/2025 by MarketBeat.com Staff
From Our Partners